Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.
Enviva Inc. today announced that on January 23, 2024 it received notification from the New York Stock Exchange that the Company is no longer in compliance with NYSE continued listing criteria.
Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.
Shares of Enviva Inc. (NYSE:EVA – Get Free Report) have been assigned an average recommendation of “Reduce” from the six research firms that are currently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and one has given a buy recommendation to […]